Veterinary Medicines

PARACOX ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Not authorised
  • Eimeria tenella, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria acervulina, strain HP, Live
Download as PDF

Product identification

Medicine name:
PARACOX ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Eimeria tenella, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria acervulina, strain HP, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria tenella, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria praecox, strain HP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria necatrix, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria mitis, strain HP, Live
    1000.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria maxima, strain CP, Live
    200.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria maxima, strain MFP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria brunetti, strain HP, Live
    100.00
    oocyst(s)
    /
    0.10
    millilitre(s)
  • Eimeria acervulina, strain HP, Live
    500.00
    oocyst(s)
    /
    0.10
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 31896/93/18-01-1994/K-0085001
Date of authorisation status change: